Feedback / Questions
IkT-148009 - Inhibikase, Clintrex
https://www.prnewswire.com/news-releases/inhibikase-therapeutics-announces-advancement-of-ikt-148009-phase-2-201-program-following-fda-review-301565953.html
Jun 13, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next